In light of this information, NCL offers this advice to consumers when considering GLP-1 treatment options: Before seeking treatment with a GLP-1 drug, talk to your doctor or health provider to determine if you are a candidate for treatment based on your risk factors and degree of obesity
AOD-9604 does not affect the hypothalamic-pituitary axis, so there is no negative feedback loop to blunt the response over time
Post-injection, it's generally safe to resume your usual activities
These drugs aid glycemic control through multiple mechanisms like enhancing insulin secretion, suppressing glucagon levels, and reducing appetite to induce weight loss
You used to walk into a room and know exactly why you were there
If you have diabetes or are at higher cardiometabolic risk, expect HbA1c and fasting glucose every 3 to 6 months